Image de couverture de livre

Featured Cover

Fuente: Wiley Open Access

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Tarek Hassanein, Andrew P. Keaveny, Parvez Mantry, Alastair D. Smith, Michael P. McRae, John Kittelson, Steve Helmke, Gregory T. Everson
Format:	Artículo Open Access
Publié:	Wiley 2024
Sujets:	Alimentary Pharmacology & Therapeutics
Accès en ligne:	Acceder al recurso
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Liver function and portal‐systemic shunting quantified by the oral cholate challenge test and risk for large oesophageal varices
par: Tarek Hassanein, et autres
Publié: (2024)

Editorial: Reading the cholate—A new gateway to portal hypertension and oesophageal varices: Authors' reply
par: Tarek Hassanein, et autres
Publié: (2024)

Cholate Shunt, Oral Cholate Challenge and Endoscopic Lesions of Portal Hypertension: The SHUNT‐V Study
par: Mitchell Shiffman, et autres
Publié: (2024)

Featured Cover
par: Prateek Sharma, et autres
Publié: (2025)

Featured Cover
par: Erin R. Bonner, et autres
Publié: (2025)

Featured Cover
par: Shusuke Kumazaki, et autres
Publié: (2024)

Featured Cover
par: Xingfei Pan, et autres
Publié: (2025)

Featured Cover
par: Nina Løn, et autres
Publié: (2024)

Featured Cover
par: Kai Markus Schneider, et autres
Publié: (2025)

Review Article: Drug Approval for Gastroparesis—Suggestions for Improving the Process for Positive Results
par: Michael Camilleri, et autres
Publié: (2026)

Editorial: H. pylori Treatment—Old Ingredients in New Effective Regimens. Authors' Reply
par: Olga P. Nyssen, et autres
Publié: (2025)

Review Article: Classic Bismuth Quadruple Therapy for Helicobacter pylori Infection—Questions Focused on Clinical Practice
par: Javier P. Gisbert, et autres
Publié: (2026)

Disordered Bile Acid Metabolism in Alcohol‐Related Hepatitis
par: Luke D. Tyson, et autres
Publié: (2026)

Editorial: Cardiometabolic criteria matters inMASLD
par: Margaret L. P. Teng, et autres
Publié: (2024)

Editorial: Proton Pump Inhibitors and the Changing Face of Spontaneous Bacterial Peritonitis
par: S. Quickert, et autres
Publié: (2026)

Editorial: Mesenchymal Stem Cell Therapy for Perianal Fistulising Crohn's Disease—Effective or Hype?
par: Jeffrey D McCurdy, et autres
Publié: (2024)

Editorial: Right‐Sizing Colonoscopy Referrals for Patients With Possible Signs and Symptoms of Colorectal Cancer
par: Nicole P. Mirabadi, et autres
Publié: (2025)

Editorial: Effectiveness and Safety of Ustekinumab in Ulcerative Colitis—Where We Are Now in Real Life. Authors' Reply
par: María Chaparro, et autres
Publié: (2024)

Editorial: Understanding Factors Associated With Abdominal Pain in Ulcerative Colitis—No Surprises But the Usual Suspects Need Greater Attention
par: Weilun Gao, et autres
Publié: (2024)

Letter: Real‐Life Evaluation of Effectiveness of Mesenchymal Stem Cell Treatment in Fistulising Crohn's Disease Emphasises the Importance of Appropriate Patient Selection and Centre Expertise
par: Weilun Gao, et autres
Publié: (2024)

Editorial: Optimal Treatment for Older Patients With Inflammatory Bowel Disease: How to Detect and Manage Frailty? Authors' Reply
par: A. B. Fons, et autres
Publié: (2026)

Letter on ‘Clinical Features of Portal Hypertension and Their Prognostic Implications in Patients With Autoimmune Hepatitis’: Authors' Reply
par: Lukas Burghart, et autres
Publié: (2026)

Letter: Why Assessment of ChILI Severity Accurately Matters?
par: Mar Riveiro‐Barciela, et autres
Publié: (2024)

Volatomics for Diagnosis and Risk Stratification of MASLD: A Proof‐Of‐Concept Study
par: R. Sinha, et autres
Publié: (2025)

Editorial: Cholestasis Is an Important Marker for Evaluating Clinical Outcomes and Prognosis in Severe Burns and Critically Ill Patients
par: Andrew T. Roberts, et autres
Publié: (2026)

Letter: Incremental Value and Outcome Modelling in Frailty Assessment for Older Patients with Inflammatory Bowel Disease. Author's Reply
par: A. B. Fons, et autres
Publié: (2026)

Letter: Addressing opioid exposure and associated harms in patients with IBD
par: Christian P. Selinger, et autres
Publié: (2024)

Letter: Meta‐Analysis: Prevalence of Frailty and Associated Adverse Events in Inflammatory Bowel Disease—Authors' Reply
par: Isabel Carbery, et autres
Publié: (2024)

Editorial: Sequencing rescue therapy for acute severe ulcerative colitis—Ready for revision?
par: L. A. A. P. Derikx, et autres
Publié: (2024)

Letter: Third‐line therapy in acute severe ulcerative colitis, exploring the uncertainty and unanswered questions—Authors' reply
par: María José García, et autres
Publié: (2024)

Letter on: ‘Impact of Frailty on the Prognosis of Patients With Liver Cirrhosis Undergoing Insertion of a TIPS ’
par: Sai Kiran Kuchana, et autres
Publié: (2026)

Editorial: Sequencing rescue therapy for acute severe ulcerative colitis—Ready for revision? Authors' reply
par: María José García, et autres
Publié: (2024)

Letter: Balancing Cost and Consequence of Colon Capsule Endoscopy in Colorectal Cancer Pathways—Finding the Sweet Spot
par: Ian Io Lei, et autres
Publié: (2025)

Liver Fibrosis and the Risk of Coronary Artery Disease, Stent Thrombosis, Restenosis and Adverse Clinical Outcomes
par: Na Tian, et autres
Publié: (2025)

Editorial: Inflammatory Bowel Disease and Dietary Emulsifiers—A Conundrum That Continues. Authors' Reply
par: Jessica A. Fitzpatrick, et autres
Publié: (2025)

Letter: Dietary emulsifiers and intestinal health—The beginning of an evolving story: Authors’ reply
par: Jessica A. Fitzpatrick, et autres
Publié: (2024)

Editorial: Managing the Moving Target—Dose Adjustments in Inflammatory Bowel Disease. Authors' Reply
par: Cristina Rubín de Célix, et autres
Publié: (2025)

Review article: Evidence‐based dietary management of inflammatory bowel disease
par: Peter R. Gibson, et autres
Publié: (2024)

Editorial: How often can we get the right diagnosis after bone marrow transplant in patients with abnormal liver function tests?
par: C. Gaume, et autres
Publié: (2024)

Editorial: Emulsifiers and thickeners in our food—Do they alter gut permeability? Authors' reply
par: Jessica A. Fitzpatrick, et autres
Publié: (2024)